Consensus for HER2 alterations testing in non-small-cell lung cancerShengxiang Ren, Fred R. Hirsch, Jianming Ying et al.|ESMO Open|2022Cited by 110
1280P Sitravatinib + tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)Qing Zhou, Yi‐Long Wu, C. Fei et al.|Annals of Oncology|2021Cited by 2